These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35480865)

  • 1. In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer.
    Sun X; Zhang Y; Chen Y; Xin S; Jin L; Liu X; Zhou Z; Zhang J; Mei W; Zhang B; Yao X; Yang G; Ye L
    Oxid Med Cell Longev; 2022; 2022():3170950. PubMed ID: 35480865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a propionate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis in bladder cancer.
    Zheng F; Wang Z; Li S; Xiong S; Yuan Y; Zeng J; Tan Y; Liu X; Xu S; Fu B
    Eur J Med Res; 2024 Jul; 29(1):393. PubMed ID: 39075554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel liquid-liquid phase separation gene signature for bladder cancer.
    Guo S; Su Q; Yang Z; Mo W
    Sci Rep; 2024 Sep; 14(1):22552. PubMed ID: 39343809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
    Jiang C; Liu Y; Wen S; Xu C; Gu L
    Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer.
    Wang L; Wang Y; Bi J
    Funct Integr Genomics; 2022 Oct; 22(5):797-811. PubMed ID: 35896848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer.
    Sun X; Xin S; Li W; Zhang Y; Ye L
    Front Genet; 2022; 13():928778. PubMed ID: 35846128
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.
    Lin X; Zheng J; Cai X; Liu L; Jiang S; Liu Q; Sun Y
    BMC Cancer; 2024 May; 24(1):571. PubMed ID: 38720279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
    Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
    Front Immunol; 2022; 13():783495. PubMed ID: 35222371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses.
    Chen Q; Yin G; He X; Jiang T; Zhou H; Wu Y; Li Y
    Evid Based Complement Alternat Med; 2022; 2022():4351005. PubMed ID: 36225190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X; Zhang M; Zhang X; Zhu X; Wang J
    BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
    Ye Y; Chen Z; Shen Y; Qin Y; Wang H
    FEBS Open Bio; 2021 Nov; 11(11):3153-3170. PubMed ID: 33386701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
    Li X; Fu S; Huang Y; Luan T; Wang H; Wang J
    BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Lipid Metabolism-Related Genes for Predicting Tumor Immune Microenvironment Status and Prognosis in Prostate Cancer.
    Zhang Y; Kong X; Xin S; Bi L; Sun X
    J Oncol; 2022; 2022():8227806. PubMed ID: 36106334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
    Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
    Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.